We are announcing a five-year foundation model licensing partnership with GSK including $50M in upfront and near-term capital, and annual model licensing fees, to transform cancer R&D.
GSK Licenses NOETIK’s OCTO-Virtual Cell…
We are announcing a five-year foundation model licensing partnership with GSK including $50M in upfront and near-term capital, and annual model licensing fees, to transform cancer R&D.